drugset / Trial / NCT00977769

Carbetocin Versus Oxytocin and Hemodynamic Effects

NCT00977769

Phase 4 Completed 76 enrolled Oslo University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.

Timeline

Start
2009-11
Primary completion
2011-08
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbetocin Peptide 100 ug
Comparator Oxytocin Peptide 5 iu Intravenous

Indications

No indication recorded.